Literature DB >> 25242745

Autoantibody Profiling in a Cohort of Pediatric and Adult Patients With Autoimmune Hepatitis.

Danilo Villalta1, Elia Girolami2, Maria Grazia Alessio3, Maria Concetta Sorrentino4, Marilina Tampoia5, Ignazio Brusca6, Massimo Daves7, Brunetta Porcelli8, Giuseppina Barberio9, Mariaelisabetta Conte1, Lisa Pantarotto1, Nicola Bizzaro10.   

Abstract

BACKGROUND: Autoimmune hepatitis (AIH) is a rare condition characterized by the presence of autoantibodies distinctive of type 1 AIH (AIH-1) and type 2 AIH (AIH-2). The aim of this study was to evaluate the autoantibody profile in a cohort of pediatric and adult AIH patients, using both indirect immunofluorescence (IIF) and a new multiplexed line-blot assay.
METHODS: Sera from 63 pediatric and 53 adult AIH patients were tested for antinuclear (ANA), antismooth muscle (SMA), anti-liver kidney microsome 1 (anti-LKM1), anti-liver cytosol 1 (anti-LC1) autoantibodies using IIF methods; for anti-LKM1, anti-LC1, and soluble liver antigen/liver-pancreas (anti-SLA/LP) autoantibodies using the line-blot; for anti-F-actin autoantibodies using IIF both on VSM47 cell-line and on rat intestinal epithelial cells.
RESULTS: AIH-1 was the most common type of AIH in the adult cohort (73.6%), while AIH-2 was the most common AIH in the pediatric cohort (61.9%). Both in adult and pediatric AIH-2 anti-LKM1 were the prevalent autoantibodies. In pediatric AIH-2 anti-LC1 autoantibodies were more frequent than in adult AIH-2 (59 vs. 28.6%), and in 35.9% of cases they were present alone. In 17 patients anti-LC1 autoantibodies were detected only with the line-blot assay. The levels of anti-LKM1 and of anti-LC1 were not different between adult and pediatric AIH, and the overall agreement between the results obtained with the two IIF methods for F-actin detection was 98.8% (CI 95%: 94.4-99.7%).
CONCLUSIONS: The line-blot assay showed a higher sensitivity than IIF for anti-LC1 detection. Anti-LKM1 and anti-LC1 autoantibody levels are not different in adults and children. An almost perfect agreement between the two IIF methods for anti-F-actin detection has been observed.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  anti-F-actin; autoantibodies; autoimmune hepatitis; indirect immunofluorescence; multiplexed line-blot; reference intervals

Mesh:

Substances:

Year:  2014        PMID: 25242745      PMCID: PMC6807246          DOI: 10.1002/jcla.21813

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  20 in total

1.  Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.

Authors:  Susana Vitozzi; Idriss Djilali-Saiah; Pascal Lapierre; Fernando Alvarez
Journal:  Autoimmunity       Date:  2002-12       Impact factor: 2.815

2.  Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group.

Authors:  Diego Vergani; Fernando Alvarez; Francesco B Bianchi; Eduardo L R Cançado; Ian R Mackay; Michael P Manns; Mikio Nishioka; Edward Penner
Journal:  J Hepatol       Date:  2004-10       Impact factor: 25.083

Review 3.  Auto-antibodies in autoimmune hepatitis: anti-soluble liver antigen (SLA).

Authors:  Catherine Johanet; Eric Ballot
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-02-03       Impact factor: 2.947

4.  Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.

Authors:  Danilo Villalta; Nicola Bizzaro; Mirella Da Re; Renato Tozzoli; Lars Komorowski; Elio Tonutti
Journal:  Autoimmunity       Date:  2008-02       Impact factor: 2.815

Review 5.  Serum autoantibodies: a road map for the clinical hepatologist.

Authors:  Francesca Meda; Massimo Zuin; Pietro Invernizzi; Diego Vergani; Carlo Selmi
Journal:  Autoimmunity       Date:  2008-02       Impact factor: 2.815

6.  Autoimmune hepatitis in childhood: a 20-year experience.

Authors:  G V Gregorio; B Portmann; F Reid; P T Donaldson; D G Doherty; M McCartney; A P Mowat; D Vergani; G Mieli-Vergani
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

7.  Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis.

Authors:  A Granito; L Muratori; P Muratori; G Pappas; M Guidi; F Cassani; U Volta; A Ferri; M Lenzi; F B Bianchi
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

8.  Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.

Authors:  Albert J Czaja; Peter T Donaldson; Ansgar W Lohse
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

Review 9.  Autoimmune hepatitis.

Authors:  P Obermayer-Straub; C P Strassburg; M P Manns
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

10.  Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis.

Authors:  E Stechemesser; R Klein; P A Berg
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

View more
  4 in total

Review 1.  Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review.

Authors:  Renato Tozzoli; Danilo Villalta; Nicola Bizzaro
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

2.  Tryptophan-kynurenine profile in pediatric autoimmune hepatitis.

Authors:  Simon D Lytton; Marcin Osiecki; Bożena Cukrowska; Aldona Wierzbicka; Maria Goliszek; Piotr Socha; Wojciech Janczyk; Dilek Dayanakli; Dieter Abendroth; Sabine Kramp; Kai Fechner; Thomas Scheper; Michael Mahler; Chelsea Bentow; Dimietrios Bogdanos; Dietmar Fuchs; Marek Woynarowski
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

Review 3.  B cells in autoimmune hepatitis: bystanders or central players?

Authors:  Christoph Schultheiß; Silja Steinmann; Ansgar W Lohse; Mascha Binder
Journal:  Semin Immunopathol       Date:  2022-04-29       Impact factor: 11.759

Review 4.  Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice.

Authors:  Benedetta Terziroli Beretta-Piccoli; Giorgina Mieli-Vergani; Diego Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-07       Impact factor: 10.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.